3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
Oxaliplatin
21
Capecitabine
19
Fluorouracil
16
Bevacizumab
16
Esomeprazole
11
Sorafenib
10
Irinotecan
9
Leucovorin
8
Radiofrequency Ablation
7
Propofol
7
Bismuth
7
Morphine
6
Gemcitabine
6
Folfox protocol
6
Amoxicillin
6
lenvatinib
5
gadolinium ethoxybenzyl DTPA
5
Tetracycline
5
Sevoflurane
5
S 1 (combination)
5
Drug Therapy
5
Control Groups
5
Cisplatin
5
sodium glycididazole
4
fish oil triglycerides
4
ferric carboxymaltose
4
Sodium Chloride
4
Ropivacaine
4
Ribavirin
4
Hepatectomy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Technetium Tc 99m Aggregated Albumin
×
Gastrointestinal
×
Clear all
NCT05848947
2025-01-29
MAApping
Sirtex Medical
Phase 4
Completed
5 enrolled
9 charts